Bimekizumab speed of response in patients with moderate to severe plaque psoriasis: Results from four phase 3/3b trials (BE VIVID, BE READY, BE SURE, and BE RADIANT). J of Skin. 2022;6(6):s69. doi:10.25251/skin.6.supp.69